Vanguard Group
ISRG icon

Vanguard Group’s Intuitive Surgical ISRG Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$18.1B Buy
33,335,833
+670,302
+2% +$364M 0.29% 49
2025
Q1
$16.2B Buy
32,665,531
+453,335
+1% +$225M 0.29% 49
2024
Q4
$16.8B Buy
32,212,196
+360,591
+1% +$188M 0.29% 49
2024
Q3
$15.6B Buy
31,851,605
+250,257
+0.8% +$123M 0.28% 53
2024
Q2
$14.1B Buy
31,601,348
+732,728
+2% +$326M 0.27% 55
2024
Q1
$12.3B Buy
30,868,620
+493,126
+2% +$197M 0.24% 63
2023
Q4
$10.2B Buy
30,375,494
+507,267
+2% +$171M 0.22% 75
2023
Q3
$8.73B Buy
29,868,227
+196,316
+0.7% +$57.4M 0.21% 79
2023
Q2
$10.1B Buy
29,671,911
+142,179
+0.5% +$48.6M 0.24% 68
2023
Q1
$7.54B Buy
29,529,732
+104,546
+0.4% +$26.7M 0.19% 90
2022
Q4
$7.81B Buy
29,425,186
+141,620
+0.5% +$37.6M 0.21% 83
2022
Q3
$5.49B Buy
29,283,566
+282,881
+1% +$53M 0.16% 110
2022
Q2
$5.82B Buy
29,000,685
+481,378
+2% +$96.6M 0.16% 110
2022
Q1
$8.6B Buy
28,519,307
+457,262
+2% +$138M 0.2% 85
2021
Q4
$10.1B Buy
28,062,045
+18,742,678
+201% +$6.73B 0.23% 72
2021
Q3
$9.26B Buy
9,319,367
+116,434
+1% +$116M 0.23% 76
2021
Q2
$8.46B Buy
9,202,933
+60,961
+0.7% +$56.1M 0.21% 80
2021
Q1
$6.76B Buy
9,141,972
+14,081
+0.2% +$10.4M 0.18% 92
2020
Q4
$7.47B Sell
9,127,891
-67,293
-0.7% -$55.1M 0.22% 78
2020
Q3
$6.52B Sell
9,195,184
-96,135
-1% -$68.2M 0.22% 80
2020
Q2
$5.29B Buy
9,291,319
+48,562
+0.5% +$27.7M 0.19% 91
2020
Q1
$4.58B Buy
9,242,757
+234,532
+3% +$116M 0.2% 94
2019
Q4
$5.33B Buy
9,008,225
+98,406
+1% +$58.2M 0.18% 99
2019
Q3
$4.81B Buy
8,909,819
+83,760
+0.9% +$45.2M 0.18% 100
2019
Q2
$4.63B Buy
8,826,059
+169,521
+2% +$88.9M 0.17% 100
2019
Q1
$4.94B Buy
8,656,538
+125,590
+1% +$71.7M 0.19% 91
2018
Q4
$4.09B Buy
8,530,948
+217,527
+3% +$104M 0.18% 95
2018
Q3
$4.77B Buy
8,313,421
+29,260
+0.4% +$16.8M 0.19% 92
2018
Q2
$3.96B Buy
8,284,161
+167,903
+2% +$80.3M 0.17% 110
2018
Q1
$3.35B Buy
8,116,258
+125,395
+2% +$51.8M 0.15% 124
2017
Q4
$2.92B Buy
7,990,863
+5,414,779
+210% +$1.98B 0.13% 148
2017
Q3
$2.69B Buy
2,576,084
+52,057
+2% +$54.4M 0.13% 151
2017
Q2
$2.36B Buy
2,524,027
+20,210
+0.8% +$18.9M 0.12% 175
2017
Q1
$1.92B Buy
2,503,817
+30,306
+1% +$23.2M 0.1% 206
2016
Q4
$1.57B Buy
2,473,511
+64,080
+3% +$40.6M 0.09% 248
2016
Q3
$1.75B Buy
2,409,431
+82,826
+4% +$60M 0.1% 205
2016
Q2
$1.54B Buy
2,326,605
+77,521
+3% +$51.3M 0.1% 228
2016
Q1
$1.35B Buy
2,249,084
+61,460
+3% +$36.9M 0.09% 244
2015
Q4
$1.19B Buy
2,187,624
+70,222
+3% +$38.4M 0.08% 267
2015
Q3
$973M Buy
2,117,402
+40,242
+2% +$18.5M 0.07% 303
2015
Q2
$1.01B Buy
2,077,160
+48,708
+2% +$23.6M 0.07% 317
2015
Q1
$1.02B Buy
2,028,452
+93,621
+5% +$47.3M 0.07% 313
2014
Q4
$1.02B Buy
1,934,831
+59,493
+3% +$31.5M 0.07% 294
2014
Q3
$866M Sell
1,875,338
-65,559
-3% -$30.3M 0.07% 313
2014
Q2
$799M Buy
1,940,897
+43,789
+2% +$18M 0.06% 346
2014
Q1
$831M Buy
1,897,108
+53,161
+3% +$23.3M 0.07% 307
2013
Q4
$708M Sell
1,843,947
-53,310
-3% -$20.5M 0.06% 343
2013
Q3
$714M Buy
1,897,257
+18,254
+1% +$6.87M 0.07% 307
2013
Q2
$952M Buy
+1,879,003
New +$952M 0.1% 202